Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-02-06Clinical Trial Update: A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis [Phase 2]
Phase 2 study of ATI-502 topical solution for atopic dermatitis completed; results posted in 2020.
-
FDA approval · 2020-01-27FDA Approved: CLOBETASOL PROPIONATE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's generic clobetasol propionate topical product under an original application, expanding access…
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis [Phase 2]
Phase 2 trial comparing safety of lebrikizumab to topical corticosteroids in adults with atopic dermatitis; study completed.
-
CLINICAL_TRIALS trial_result · 2020-01-22Clinical Trial Update: Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis [Phase 3]
Phase 3 trial update for baricitinib in moderate to severe atopic dermatitis; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: A Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis [Phase 3]
Phase 3 trial update for baricitinib in moderate-to-severe atopic dermatitis has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-01-14Clinical Trial Update: Apremilast for Atopic Dermatitis - A Pilot Study in Adults [Phase 2]
Phase 2 pilot study evaluating apremilast for atopic dermatitis has completed with results posted.
-
FDA approval · 2019-12-30FDA Approved: CLOBETASOL PROPIONATE — Original Application (Torrent Pharmaceuticals Limited)
FDA approved an original application for clobetasol propionate topical from Torrent Pharmaceuticals Limited (generic).
-
FDA approval · 2019-12-18FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved an original application for Betamethasone dipropionate by Lupin Pharmaceuticals, Inc., granting a generic topical corticosteroi…
-
CLINICAL_TRIALS trial_result · 2019-12-10Clinical Trial Update: Study to Evaluate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis [Phase 3]
Phase 3 trial evaluating PF-04965842 for moderate to severe atopic dermatitis has completed and results were posted in 2019.
-
FDA approval · 2019-11-29FDA Approved: TRIAMCINOLONE ACETONIDE — Original Application (Encube Ethicals, Inc.)
The FDA approved Encube Ethicals' Triamcinolone Acetonide Ointment USP, 0.05% as an original generic topical corticosteroid product through …
-
CLINICAL_TRIALS trial_result · 2019-11-27Clinical Trial Update: Beginning Assessment of Cutaneous Treatment Efficacy of Roseomonas in Atopic Dermatitis [Phase 1, Phase 2]
A clinical trial update reports assessment of cutaneous treatment efficacy of Roseomonas for atopic dermatitis in Phase 1/Phase 2, completed…
-
FDA approval · 2019-11-26FDA Approved: FLUOCINONIDE — Original Application (Xiromed LLC)
FDA approved the original application for fluocinonide (topical corticosteroid) submitted by Xiromed LLC.
-
FDA approval · 2019-11-15FDA Approved: CLOBETASOL PROPIONATE — Original Application (Encube Ethicals, Inc.)
FDA approved the Original Application for Clobetasol Propionate Ointment USP, 0.05% (generic) by Encube Ethicals, Inc.
-
CLINICAL_TRIALS trial_result · 2019-11-07Clinical Trial Update: Evaluation of the Efficacy of an Autologous Microbiome Transplant in Adult Atopic Dermatitis Patients [Phase 1]
Phase 1 trial evaluating autologous microbiome transplant for adults with atopic dermatitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-11-05Clinical Trial Update: Study in Subjects With Moderate Atopic Dermatitis [Phase 2]
Phase 2 clinical trial update for a treatment in subjects with moderate atopic dermatitis (eczema).
-
FDA approval · 2019-10-23FDA Approved: DESONIDE — Original Application (Alembic Pharmaceuticals Inc.)
The FDA approved an original ANDA for desonide from Alembic Pharmaceuticals Inc., enabling the sale of generic desonide products.
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: Dose-ranging Study of Nemolizumab in Atopic Dermatitis [Phase 2]
Phase 2 dose-ranging study of nemolizumab in atopic dermatitis has been completed with posted results.
-
FDA approval · 2019-10-21FDA Approved: CLOBETASOL PROPIONATE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approves Alembic Pharmaceuticals' original ANDA for clobetasol propionate topical.
-
CLINICAL_TRIALS trial_result · 2019-10-18Clinical Trial Update: Insulin Sensitivity in Patients With Atopic Dermatitis
A completed clinical trial investigating insulin sensitivity in patients with atopic dermatitis and type 2 diabetes, with results posted in …
-
CLINICAL_TRIALS trial_result · 2019-10-14Clinical Trial Update: LEO 29102 Cream in the Treatment of Atopic Dermatitis [Phase 2]
Phase 2 trial results for LEO 29102 Cream in atopic dermatitis have been posted after study completion.
-
CLINICAL_TRIALS trial_result · 2019-10-10Clinical Trial Update: A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis [Phase 4]
Phase 4 trial update of Crisaborole Ointment 2% in toddlers with mild to moderate atopic dermatitis; study completed with posted results.
-
FDA approval · 2019-10-08FDA Approved: OLUMIANT — Supplemental Application (Eli Lilly and Company)
FDA approves Eli Lilly's supplemental application for OLUMIANT (baricitinib). This action updates the labeling to reflect expanded indicatio…
-
CLINICAL_TRIALS trial_result · 2019-10-04Clinical Trial Update: The Efficacy of Cimetidin for Acute - Extrinsic Atopic Dermatitis Treated With Standard Therapy [Phase 3]
Phase 3 trial update evaluating the efficacy of cimetidine as an adjunct to standard therapy for acute extrinsic atopic dermatitis with elev…
-
FDA approval · 2019-10-02FDA Approved: CLOBETASOL PROPIONATE — Original Application (Micro Labs Limited)
The FDA approved Micro Labs Limited's original application for clobetasol propionate topical, a potent corticosteroid, for inflammatory and …
-
FDA approval · 2019-10-02FDA Approved: CLOBETASOL PROPIONATE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's original application for clobetasol propionate topical, a high-potency corticosteroid, enabli…